Why the study?
Although the cardioinhibitory role of cardiovagal neurons in nucleus ambiguus is well established, the nature and functionality of cardiovagal neurons in dorsal motor nucleus of the vagus is less clear.
Cardiovagal neurons in the dorsal motor nucleus of the vagus are uniquely hyperexcitable and capable of inducing robust bradycardia and anxiolysis.
Answers are grounded in this paper and cite their sources.
DMV cholinergic activation drives bradycardia; leaves open therapeutic targeting in human arrhythmias.
Summary Cardiovagal neurons (CVNs) innervate cardiac ganglia through the vagus nerve to control cardiac function. Although the cardioinhibitory role of CVNs in nucleus ambiguus (CVN NA ) is well established, the nature and functionality of CVNs in dorsal motor nucleus of the vagus (CVN DMV ) is less clear. We therefore aimed to characterize CVN DMV anatomically, physiologically, and functionally. Optogenetically activating cholinergic DMV neurons resulted in robust bradycardia through peripheral muscarinic (parasympathetic) and nicotinic (ganglionic) acetylcholine receptors, but not beta-1-adrenergic (sympathetic) receptors. Retrograde tracing from the cardiac fat pad labeled CVN NA and CVN DMV through the vagus nerve. Using whole cell patch clamp, CVN DMV demonstrated greater hyperexcitability and spontaneous action potential firing ex vivo despite similar resting membrane potentials, compared to CVN NA . Chemogenetically activating DMV also caused significant bradycardia with a correlated reduction in anxiety-like behavior. Thus, DMV contains uniquely hyperexcitable CVNs capable of cardioinhibition and robust anxiolysis.
No takes yet. Share an insight, caveat, or question.
Strain et al. (2023) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: